Cervical Cancer Trial, Recruiting NCT06843720 Sponsor: M.D. Anderson Cancer Center Condition: Cervical Cancer
Back to Cervical Cancer

Cervical Cancer Trial, Recruiting

NCT06843720
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

This trial involves several different groups of people. Depending on which group applies, the criteria are:

Patients eligible for cervical cancer screening:

  • People who currently live in the state of Texas
  • People who receive care at a clinic that is partnering with this study
  • Women and people who have a cervix
  • People aged 25 to 65
  • People who are due or overdue for a cervical cancer screening

Patients and community members for formative research:

  • People who research staff have specifically identified as a relevant stakeholder for this part of the study

Healthcare providers, clinic staff, and health system stakeholders:

  • People who work at least part-time at a health system that is partnering with this study, and who are aged 18 or older

Project ECHO participants:

  • People who take part in at least one Project ECHO session, and who are aged 18 or older

Other clinical network participants:

  • People who take part in at least one clinical network session, and who are aged 18 or older

Who may not be able to join:

For cervical cancer screening patients:

  • People who are currently pregnant
  • People who have had a complete hysterectomy (full surgical removal of the uterus)
  • People who have a history of cervical cancer

For all other groups:

  • People who are not able to communicate in English or Spanish
  • Children, pregnant women, adults with cognitive impairment, or people who are currently incarcerated are not permitted to participate in any part of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 713- 745-5008

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 February 2025
Est. completion
31 March 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Safety and Adverse Events (AEs). Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 4.03

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov